Xtralite Mild Cream
Prescription required
Highlights
composition with strength
Azelaic Acid (10%w/w), Tretinoin (0.025%w/w)
description
Effective treatment for melasma, reduces dark spots and pigmentation, improves skin texture and smoothness
key benefits
Treatment of Melasma
side effects
Burning sensation , Application site redness and Stinging sensation
how to use
For external use only. Apply the cream to the affected area after cleaning and drying it. Use it as directed by your doctor and check the label for instructions.
alcohol interaction
Safe
pregnancy interaction
Unsafe
lactation interaction
Caution
driving interaction
Safe
kidney interaction
Safe
liver interaction
Safe
Information
disclaimer
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship.
While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
customer care details
In case of any issue, contact us
E-mail address: support@zeptonow.com
Seller Name
Commodum Groceries Private Limited
Seller Address
Fourth Floor, Unit No. 442, JMD Megapolis, Village Tikri, Tehsil Badshahpur Sohna Road, Sector 48, Gurgaon, Gurgaon, Gurgaon- 122018, Haryana, India.
Pharmacy License No.
RLF20HR2025000661, RLF21HR2025000656
Country of Origin
India
Manufacturer or Marketer Name
La Pristine Bioceuticals Private Limited
Manufacturer or Marketer Address
A-23, Sector 9, Noida-201301
Shelf Life
18 months
Expires on or after
January 2027
